Search for: "Otsuka Pharmaceutical Co., Ltd."
Results 1 - 20
of 37
Sorted by Relevance
|
Sort by Date
19 Dec 2007, 4:04 pm
Singer -- In a December 17, 2007 press release, Otsuka Pharmaceutical Co., Ltd. and PDL BioPharma, Inc. announced a finalized agreement in which Otsuka acquires intellectual property related assets to IV Busulfex ® (busulfan) from PDL. [read post]
27 Mar 2008, 10:29 pm
The U.S. unit of Otsuka’s Pharmaceutical Co. [read post]
17 Nov 2010, 7:05 pm
DNJ on Monday, Nov. 15 upheld the Abilify patent of Otsuka Pharmaceutical Co. [read post]
1 Feb 2015, 9:59 pm
Otsuka Pharmaceutical Co. [read post]
28 Mar 2012, 1:31 am
This time the drug in question is ‘atypical’ antipsychotic aripiprazole, marketed by Bristol-Meyers Squibb (BMS) as ABILIFY, under license from the patentee Otsuka Pharmaceutical Co., Ltd. [read post]
15 Oct 2015, 2:35 pm
Sandoz, 678 F.3d 1280 :In summary, the district court's careful analysis exposed the Defendants' obviousness case for what it was—a poster child for impermissible hindsight reasoning. showed up the district court.The drug in question: Aripiprazole is the active ingredient in the antipsychotic drug marketed by Otsuka Pharmaceutical Co., Ltd. [read post]
15 Mar 2015, 8:48 pm
Otsuka Pharmaceutical Co., Ltd. v. [read post]
26 May 2014, 9:59 pm
Otsuka Pharmaceutical Co. v. [read post]
3 Jul 2014, 9:40 pm
Otsuka Pharmaceutical Co. [read post]
5 May 2020, 12:35 pm
(“Akebia”) and Otsuka Pharmaceutical Co. [read post]
15 May 2018, 8:29 am
The District Court has ordered the defendants, Bristol-Myers Squibb Co., and Otsuka Pharmaceutical Co. [read post]
15 May 2018, 8:29 am
The District Court has ordered the defendants, Bristol-Myers Squibb Co., and Otsuka Pharmaceutical Co. [read post]
10 Jun 2012, 12:31 am
Generic Health Pty Ltd v Otsuka Pharmaceutical Co Ltd [2012] FCA 412 (23 April 2012) Practice and procedure – interlocutory injunction – whether application for leave to appeal should be referred to a Full Court Generic Health Pty Ltd will have the opportunity to appeal the decision of a single judge of the Federal Court of Australia granting a preliminary injunction preventing it from launching a generic version of the… [read post]
7 May 2012, 10:51 am
By Jason Rantanen Otsuka Pharmaceutical Co., Ltd. v. [read post]
8 Nov 2023, 4:15 am
Co., Ltd. v. [read post]
8 Nov 2023, 4:15 am
Co., Ltd. v. [read post]
15 Oct 2015, 6:59 am
" Otsuka Pharmaceutical Co., Ltd. v. [read post]
4 Sep 2012, 7:38 am
James Jang In Otsuka Pharmaceutical Co. v. [read post]
22 May 2018, 12:20 pm
The drug companies responsible for Rexulti in the US are Otsuka Pharmaceutical Co., Ltd. [read post]
5 Jul 2015, 4:18 am
’ I explained that Swiss-type claims are treated as if they cover any and every method of making a medicament of any kind that includes the compound as an active ingredient, and with the intention of it being used to treat the new condition.By sheer coincidence, on 29 June 2015 Justice Yates, in the Federal Court of Australia, handed down a ruling in Otsuka Pharmaceutical Co., Ltd v Generic Health Pty Ltd (No 4) [2015] FCA 634, in which he has… [read post]
